Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
2
Neutral
7
Bullish
5
Bearish
26
Neutral
7
Bullish
13
Bearish
24
Neutral
0
Bullish
8
Bearish
24
Neutral
0
Bullish
8
Bearish
24
Neutral
0
Bullish
8
Bearish
24
Neutral
0
Bullish
8
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q3 FY25
Discovery themes featuring this stock
Inventurus Knowledge Solutions (IKS) is a tech-enabled healthcare provider enablement platform serving US healthcare organizations with a comprehensive system of action across clinical documentation, coding, revenue cycle management, patient engagement and technology-enabled services, now expanded by the strategic TruBridge and ARAI acquisitions to include an integrated EHR footprint and explainable-AI capabilities.
The July 2026 TruBridge acquisition materially expands IKS's TAM into the rural and community hospital market where TruBridge holds a ~30% share, bringing a 5+ million patient dataset and a distinct opportunity to become the integrated system of action plus system of record for ~2,100 rural hospitals, creating a mid-term cross-sell engine and AI training corpus.
IKS is deliberately building proprietary AI infrastructure: management plans to de-identify and structure TruBridge data, train specialty Small Language Models (SLMs), and combine those SLMs with ARAI-powered knowledge graphs to deliver explainable generative AI and lower reliance on expensive external LLM tokens while enabling task-level autonomy across deterministic and non-deterministic workflows.
Financially, Q1 FY27 delivered INR893 crores revenue (21% YoY; 12% constant currency) and INR294 crores reported EBITDA (33%), which adjusts to ~INR314 crores (~35% EBITDA) after removing one-time acquisition costs, with net profit around INR194 crores and robust free cash flow generation; management reiterated a FY30 True North of INR3,000 crores EBITDA with limited dilution.
Client wins and operational momentum validate the land-and-expand GTM: high‑vintage top customers, strong KLAS/Black Book feature ratings, and new large health system deals show cross-sell is working, while operational levers and technology are targeted to drive TruBridge margin improvement back to IKS mid-30s EBITDA levels over the medium term.
IT - Services
IT Enabled Services
29,319 Cr
Low Risk
38.4
30.9
1.5
10.5
1,969.00
1,262.35
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
4182.65 | 44,376 Cr | 32.74 | 6.27 | 1.39 | 21.74 | 26.41 | 14.86 | ||
1710.55 | 29,364 Cr | 38.45 | 10.49 | 0.00 | 25.77 | 27.45 | 17.90 | ||
658.65 | 26,745 Cr | 47.50 | 6.98 | 1.78 | 17.14 | 18.59 | 6.57 | ||
4388.30 | 26,087 Cr | 71.30 | 12.40 | 0.07 | 17.39 | 21.99 | 9.00 | ||
44.69 | 20,921 Cr | 20.38 | 2.05 | 0.34 | 10.04 | 13.02 | 7.98 | ||
1382.60 | 19,895 Cr | 41.64 | 4.91 | 0.00 | 12.45 | 15.31 | 10.81 | ||
818.80 | 14,542 Cr | 64.34 | 11.30 | 0.12 | 21.34 | 17.76 | 5.26 | ||
| Median: 7 Co. | — | 1382.60 | 26,087 Cr | 41.64 | 6.98 | 0.12 | 17.39 | 18.59 | 9.00 |
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Inventurus Knowledge Solutions Ltd (IKS) is currently trading at 1,707.95 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Inventurus Knowledge Solutions (IKS) is a tech-enabled healthcare provider enablement platform serving US healthcare organizations with a comprehensive system of action across clinical documentation, coding, revenue cycle management, patient engagement and technology-enabled services, now expanded by the strategic TruBridge and ARAI acquisitions to include an integrated EHR footprint and explainable-AI capabilities. The July 2026 TruBridge acquisition materially expands IKS's TAM into the rural and community hospital market where TruBridge holds a ~30% share, bringing a 5+ million patient dataset and a distinct opportunity to become the integrated system of action plus system of record for ~2,100 rural hospitals, creating a mid-term cross-sell engine and AI training corpus. IKS is deliberately building proprietary AI infrastructure: management plans to de-identify and structure TruBridge data, train specialty Small Language Models (SLMs), and combine those SLMs with ARAI-powered knowledge graphs to deliver explainable generative AI and lower reliance on expensive external LLM tokens while enabling task-level autonomy across deterministic and non-deterministic workflows. Financially, Q1 FY27 delivered INR893 crores revenue (21% YoY; 12% constant currency) and INR294 crores reported EBITDA (33%), which adjusts to ~INR314 crores (~35% EBITDA) after removing one-time acquisition costs, with net profit around INR194 crores and robust free cash flow generation; management reiterated a FY30 True North of INR3,000 crores EBITDA with limited dilution. Client wins and operational momentum validate the land-and-expand GTM: high‑vintage top customers, strong KLAS/Black Book feature ratings, and new large health system deals show cross-sell is working, while operational levers and technology are targeted to drive TruBridge margin improvement back to IKS mid-30s EBITDA levels over the medium term.
Over the past 52 weeks, Inventurus Knowledge Solutions Ltd has traded between a low of ₹1,262.35 and a high of ₹1,969.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Inventurus Knowledge Solutions Ltd has a market capitalization of approximately 29,363.84. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Inventurus Knowledge Solutions Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 38.45 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 29,363.84 Cr, Inventurus Knowledge Solutions Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Inventurus Knowledge Solutions Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Inventurus Knowledge Solutions Ltd is 38.45. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
IKS Health reported consolidated revenue from operations of ₹893.63 crore and consolidated net profit of ₹194 crore for the quarter ended June 30, 2026.
The stock symbol is INVU, and the company trades on the National Stock Exchange of India.
Net sales were reported at ₹857.65 crore for the March 2026 quarter, up 18.47% from ₹723.96 crore in March 2025.
Standalone net sales were ₹412.69 crore in the quarter ended March 2026, up 42.13% from ₹290.37 crore in March 2025.
